• Sonuç bulunamadı

2017 Subject Index

N/A
N/A
Protected

Academic year: 2021

Share "2017 Subject Index"

Copied!
2
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

2017 Subject Index

1H-NMR ...49

2,3-dihydro-1,4-benzodioxin-6-amine ...49

Acetohydrazide ... 285

Acinetobacter ...13

Activity of melatonin ... 75

Adenosine A2B receptors ...19

Agmatine... 127

AMPK ... 207

Androgen receptor ...274

Anti-inflammatory ...231

Anti-inflammatory activity ...108

Antibacterial activity ... 157

Antibacterial potential ...49

Antineoplastic ... 304

Antioxidant ...311

Antioxidant activity ... 174

Antiproliferative ...29

Antitubercular activity ... 157

Antiviral activity ... 157

AP-PCR ...13

Apoptosis ...169,222 Artemisia absinthium ...222

Artificial neural networks ...213

Arylidenehydrazide ... 157

Asteraceae ... 290

AUC ...108

Benzimidazole ... 285

Biodegradable ...34

Biomechanic ...65

cAMP ...19

Cancer cells ...222

Carbonic anhydrase ... 9

Carvacrol ...29

Cell death ...169

Characterization...34,280 Checkerboard ...13

Chemotherapy... 304

CHO cells...185

Chrysophthalmum montanum ... 290

Clinical trials ...84

Clonazepam ...251

Clove oil ...201

Co-crystal ... 280

Cobalt ferrite nanoparticle ...169

Colistin ...13

Comet assay ...185

Cost saving ... 304

Croscarmellose sodium ...40

CYP ... 319

Cytotoxic activity ... 290

Cytotoxicity ...201,222,231 Desloratadine ...148

Dexketoprofen trometamol ...1

Diclofenac sodium ...1,56 Dirithromycin ...191

Disintegration...40

Dissolution ...40,120,280 DNA damage ...169,185,257 Donepezil ...164

DPPH ... 179

Drug delivery ...34,56 Drug pricing ...264

Drug waste ... 304

EDCF ... 207

Endemic ...134

Endometrial cancer...141

Endothelium... 207

Enzyme activation...164

Epidermal growth factor receptor kinase ... 285

EROD activity ... 174

Ethics ...264

Eudragit® RS100 ...148

Eugenol ...201

Extended-release tablets ...213

First-derivative synchronous spectrofluorimetry ...251

Free radical scavenging activity ... 179

Genotoxicity ...201

GSTM1 ...237

GSTT1 ...237

Gynecologic cancers ... 324

Health effects ...311

Health policies ...264

HeLa ...29

Herbicide ...185

High performance liquid chromatography ... 179

Histopathology ... 65,243 HPLC ...148

Human CAI ...164

Human CAII ...164

Imidazo[2,1-b]thiazole ... 157

In vivo bioavailability study...120

IND ...84

Indion 414 ...40

Indomethacin ...108

Inflammation ...19,274,324 Inhibition ... 9

Inhibitory ... 285

Inos ...231

Insecticidal activity ... 290

Interleukin 6 ...19

Internal and external predictability ...120

Ischemia reperfusion injury ... 257

IVIVC ...120

Kollidon® SR ...191

Lead ... 9

Leaf and stem anatomy ...134

Leguminosae ...134

Lipid peroxidation ... 174

Lipoxygenase...49

Lung cancer ... 319

Lycopene ...311

Mass spectrometer ... 294

(2)

2017 Subject Index

MDA ... 179

Medicinal plants ...222

Melatonin ... 75

Memantine ...164

Microspheres ... 243

Molecular docking ...34

MTT ... 95,231 Nanoparticle ...148

Naproxen sodium ...120

Naringenin ... 9

Neuro-fuzzy logic ...213

Neutral red ...95

NF-κb ...231

NKX3.1...274

Non-small cell lung carcinoma ...237

NSAID ...274

Ocular drug delivery...191

Ononis ...134

Origanum acutidens ...29

Ovarian cancer ...141

Oxazolidinones ... 174

Paroxetine hydrochloride ...251

Pathway ... 324

Patient rights ...264

Pendimethalin ...185

Pharmaceutical industry ...264

Pharmacists ...264

Pharmacoeconomy ... 304

Pharmacological activity ...201

Phase 0 ...84

Phytoconstituents ... 324

Phytomelatonin ... 75

Phytotoxic activity ... 290

Pistacia atlantica ...65

Plant phenolics ...95

PLGA ...56

Poloxamers ...56

Poly(ε-caprolactone) ...56

Polymeric nanoparticles ...191

Polymorphism ... 237,319 Preclinical testing ...84

Prostate cancer ...274

Protein expression ...237

Pseudo ternary phase diagram ...108

Pycnogenol ... 257

Quality by design ...213

Quercetin ... 280

Quetiapine fumarate ...213

Radical scavenging ...29

Rat ... 127

Response to chemotherapy ... 319

Rho-kinaz ... 207

Salicylic acid...1

Scorzonera latifolia ... 179

sE-cadherin ...141

Secondary metabolites ... 324

Self emulsifying drug delivery system ...108

Skeletal muscle ...19

Skin ...65

Skin reaction ... 127

Sodium starch glycolate ...40

Solvent evaporation ... 280

Statistical assessment ... 294

Subcutaneous route ... 127

Substance abuse ... 294

Succinic acid ... 280

Survival ... 319

Sustained release ...120

Synthesis ... 174

Tanacetum argenteum subsp. argenteum...231

TGF-β1 ...141

Thermosensitive hydrogel ...56

Tigecycline ...13

Time-kill ...13

Toxicity ...127,201 Turkey ...134

UPLC ...1

Urine ... 294

Vaccine delivery ... 243

Validation ...1

Vitronectin ...141

Wet granulation ...213

Wetting ...40

Wound healing ...65

Zeta potential ...108

Referanslar

Benzer Belgeler

Cone beam computed tomography/Konik ışınlı bilgisayarlı tomografi ...65. Cone beam computerized tomography/Konik ışınlı bilgisayarlı

Atypical neuroleptic malignant syndrome/Atipik nöroleptik malign sendrom ...31.

Female Sexual Function Index / Kadın Seksüel Fonksiyon İndeksi

Pencil lead ...521. Penetrating

Epidermal growth factor receptor (EGFR) has been implicated as a factor indicating tumour progression or as a prognostic factor in non-small cell lung cancer (NSCLC), in which

Psikiyatride Güncel Yaklaşımlar - Current Approaches

[r]

Chronic hepatitis C/Kronik hepatit C ...6,50 Chronic liver disease/Kronik karaciğer hastalığı